BAMS
Bellevue Asset Management (Switzerland) Portfolio holdings
AUM
$656M
This Quarter Return
+12.16%
1 Year Return
+11.48%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$717M
AUM Growth
–
Cap. Flow
+$717M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
28.86%
Holding
141
New
140
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Biogen
BIIB
|
$29.9M |
| 2 |
Medtronic
MDT
|
$26.5M |
| 3 |
CELG
Celgene Corp
CELG
|
$26M |
| 4 |
Abbott
ABT
|
$23.5M |
| 5 |
Gilead Sciences
GILD
|
$22.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 85.27% |
| 2 | Financials | 0.88% |
| 3 | Industrials | 0.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ionis Pharmaceuticals
IONS
$6.79B
| $9.36M | 1.31% |
+147,000
| New | +$9.36M |
|
27
McKesson
MCK
$85.4B
| $9.27M | 1.29% |
+41,000
| New | +$9.27M |
|
|
MNK
28
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $8.87M | 1.24% |
+70,000
| New | +$8.87M |
|
29
Teva Pharmaceuticals
TEVA
$21.1B
| $8.72M | 1.22% |
+140,000
| New | +$8.72M |
|
30
Becton Dickinson
BDX
$55.3B
| $8.42M | 1.17% |
+58,608
| New | +$8.42M |
|
31
Cardinal Health
CAH
$35.5B
| $8.12M | 1.13% |
+90,000
| New | +$8.12M |
|
32
Incyte
INCY
$16.5B
| $8.1M | 1.13% |
+88,352
| New | +$8.1M |
|
|
RCPT
33
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $7.92M | 1.1% |
+48,000
| New | +$7.92M |
|
34
Acadia Pharmaceuticals
ACAD
$4.38B
| $7.53M | 1.05% |
+231,000
| New | +$7.53M |
|
35
Ligand Pharmaceuticals
LGND
$3.15B
| $7.18M | 1% |
+93,160
| New | +$7.18M |
|
36
Boston Scientific
BSX
$156B
| $7.17M | 1% |
+404,000
| New | +$7.17M |
|
|
MDVN
37
DELISTED
MEDIVATION, INC.
MDVN
| $7.01M | 0.98% |
+54,300
| New | +$7.01M |
|
|
AKRX
38
DELISTED
Akorn, Inc.
AKRX
| $6.89M | 0.96% |
+145,000
| New | +$6.89M |
|
39
Intuitive Surgical
ISRG
$170B
| $6.84M | 0.95% |
+13,550
| New | +$6.84M |
|
40
Alnylam Pharmaceuticals
ALNY
$58.5B
| $6.68M | 0.93% |
+64,000
| New | +$6.68M |
|
|
LCI
41
DELISTED
Lannett Company, Inc.
LCI
| $6.61M | 0.92% |
+97,550
| New | +$6.61M |
|
42
Molina Healthcare
MOH
$9.8B
| $6.39M | 0.89% |
+94,960
| New | +$6.39M |
|
|
AET
43
DELISTED
Aetna Inc
AET
| $6.29M | 0.88% |
+59,000
| New | +$6.29M |
|
44
Pfizer
PFE
$141B
| $6.26M | 0.87% |
+180,000
| New | +$6.26M |
|
45
Cigna
CI
$80.3B
| $5.83M | 0.81% |
+45,000
| New | +$5.83M |
|
46
Dr. Reddy's Laboratories
RDY
$11.8B
| $5.71M | 0.8% |
+100,000
| New | +$5.71M |
|
47
Agios Pharmaceuticals
AGIO
$2.19B
| $5.47M | 0.76% |
+58,000
| New | +$5.47M |
|
48
Alkermes
ALKS
$4.78B
| $5.27M | 0.74% |
+86,500
| New | +$5.27M |
|
49
Brookdale Senior Living
BKD
$1.83B
| $5.07M | 0.71% |
+134,140
| New | +$5.07M |
|
50
HCA Healthcare
HCA
$94.5B
| $5.04M | 0.7% |
+67,000
| New | +$5.04M |
|